Editors' Advice To Rejected Authors: Just Try, Try Again

Nearly everyone must learn to deal with rejection, and authors of research papers are no exception. Many reviewers and other knowledgeable individuals say the key is not to take rejection of one's manuscript personally, and they point out that papers turned down by one publication often have gone on to enjoy success in others. In fact, according to one observer, several papers that were initially rejected went on to earn their authors the Nobel Prize. The topic is of particular interest to new

Written byThomas Durso
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Nearly everyone must learn to deal with rejection, and authors of research papers are no exception. Many reviewers and other knowledgeable individuals say the key is not to take rejection of one's manuscript personally, and they point out that papers turned down by one publication often have gone on to enjoy success in others. In fact, according to one observer, several papers that were initially rejected went on to earn their authors the Nobel Prize.

The topic is of particular interest to newly minted researchers, who may not have had to deal with such outright professional rebuffs before. While immersed in the struggle to obtain grant support and the pressures of performing original research, perhaps for the first time, these researchers may not understand why they need to learn the skill of coping with rejection. According to publishing professionals and academic administrators, the answer is simple: It can improve one's ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies